Developer a targeted stimulator of interferon genes (STING) inhibitors intended to treat systemic sclerosis and other inflammatory diseases. The company's lead program focuses on potent and selective inhibitors of stimulators of interferon genes (STING), a key protein involved in the immune response, providing patients with new treatment options for debilitating conditions.